SMTL ID : 3ocb.2 (1 other biounit)

Akt1 kinase domain with pyrrolopyrimidine inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.70 Å

Oligo State

hetero-oligomer

Ligands

1 x XM1: (2S)-2-(4-CHLOROBENZYL)-3-OXO-3-[4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)PIPERAZIN-1-YL]PROPAN-1-AMINE(Non-covalent)

XM1.1: 21 residues within 4Å: Chain A: L.17, K.19, G.20, G.23, K.24, V.25, A.38, K.40, T.72, M.88, E.89, Y.90, A.91, E.95, E.139, N.140, M.142, T.152, D.153, F.299 Chain B: R.4 5 PLIP interactions: 4 interactions with chain A, 1 interactions with chain B Hydrophobic interactions: A:A.38, A:K.40 Hydrogen bonds: A:A.91, A:D.153, B:R.4

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Blake, J.F. et al., Discovery of pyrrolopyrimidine inhibitors of Akt. Bioorg.Med.Chem.Lett. (2010)

Release Date

2010-09-15

Peptides

v-akt murine thymoma viral oncogene homolog 1 (AKT1): A
GSK 3 beta peptide: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

B
D

v-akt murine thymoma viral oncogene homolog 1 (AKT1)

GSK 3 beta peptide

Related Entries With Identical Sequence